Insider · CIK 0002019493
Michael P Dube
Files at NTLA (Intellia Therapeutics, Inc.). First filing Jan 7, 2025, latest Oct 6, 2026.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
NTLA: Intellia Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 15Weak | NTLAsell Intellia Therapeutics, Inc. | $23k 1,864 shares | -3% | +52% from low-56% from high | |
| 35Weak | Intellia Therapeutics, Inc. | $28k 2,989 shares | -5% | +49% from low-67% from high | |
| 29Weak | Intellia Therapeutics, Inc. | $33k 1,871 shares | -3% | +199% from low-11% from high | |
| 30Weak | Intellia Therapeutics, Inc. | $25k 2,503 shares | -4% | +71% from low-53% from high | |
| 30Weak | Intellia Therapeutics, Inc. | $17k 1,372 shares | -3% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 2, 2026 | NTLA Intellia Therapeutics, Inc. | SOpen-market sale Common Stock | -1,864 | $12.43 | $23k | 65,022 | 6 d ago |
| Mar 1, 2026 | NTLA Intellia Therapeutics, Inc. | AGrant or award Common Stock | +17,250 | $0.00 | $0 | 69,527 | Mar 3, 2026 |
| Jan 5, 2026 | NTLA Intellia Therapeutics, Inc. | SOpen-market sale Common Stock | -2,989 | $9.21 | $28k | 52,277 | Jan 7, 2026 |
| Oct 1, 2025 | NTLA Intellia Therapeutics, Inc. | SOpen-market sale Common Stock | -1,871 | $17.38 | $33k | 55,266 | Oct 3, 2025 |
| Jul 2, 2025 | NTLA Intellia Therapeutics, Inc. | SOpen-market sale Common Stock | -2,503 | $9.95 | $25k | 57,137 | Jul 3, 2025 |
| Mar 1, 2025 | NTLA Intellia Therapeutics, Inc. | AGrant or award Common Stock | +14,000 | $0.00 | $0 | 59,640 | Mar 4, 2025 |
| Jan 3, 2025 | NTLA Intellia Therapeutics, Inc. | SOpen-market sale Common Stock | -1,372 | $12.18 | $17k | 45,640 | Jan 7, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.